Hyper-Personalized Medicine Market Set to Reach $5.9 Trillion by 2031
The global hyper-personalized medicine market is transforming healthcare by customizing treatments based on patients' unique genetic, molecular, and lifestyle profiles. This market, valued at $2.1 trillion in 2021, is projected to grow at a compound annual growth rate (CAGR) of 11.7%, reaching $5.9 trillion by 2031. This innovative approach enhances treatment efficacy, reduces costs, and minimizes adverse effects.
Comments
Post a Comment